Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study.
Strongman H, Korhonen P, Williams R, Bahmanyar S, Hoti F, Christopher S, Majak M, Kool-Houweling L, Linder M, Dolin P, Heintjes EM. Strongman H, et al. Among authors: dolin p. BMJ Open Diabetes Res Care. 2017 May 29;5(1):e000364. doi: 10.1136/bmjdrc-2016-000364. eCollection 2017. BMJ Open Diabetes Res Care. 2017. PMID: 28761650 Free PMC article.
Monitoring for proteinuria in patients with type 2 diabetes mellitus.
Liang H, Kennedy C, Manne S, Lin JH, Dolin P. Liang H, et al. Among authors: dolin p. BMJ Open Diabetes Res Care. 2015 Apr 9;3(1):e000071. doi: 10.1136/bmjdrc-2014-000071. eCollection 2015. BMJ Open Diabetes Res Care. 2015. PMID: 25893098 Free PMC article.
Pioglitazone, bladder cancer, and detection bias.
Dolin P. Dolin P. J Diabetes. 2014 Mar;6(2):193-4. doi: 10.1111/1753-0407.12087. Epub 2013 Oct 31. J Diabetes. 2014. PMID: 24004505 Free PMC article. No abstract available.
The risk of acute liver injury associated with the use of antibiotics--evaluating robustness of results in the pharmacoepidemiological research on outcomes of therapeutics by a European consortium (PROTECT) project.
Udo R, Tcherny-Lessenot S, Brauer R, Dolin P, Irvine D, Wang Y, Auclert L, Juhaeri J, Kurz X, Abenhaim L, Grimaldi L, De Bruin ML. Udo R, et al. Among authors: dolin p. Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:47-55. doi: 10.1002/pds.3841. Epub 2015 Aug 2. Pharmacoepidemiol Drug Saf. 2016. PMID: 26235335
45 results